EDUCATION

Undergraduate Degree

  • University of Michigan , Ann Arbor , MI

Graduate Degree

  • University of Washington , Seattle , WA

Medical School

  • University of Washington , Seattle , WA

Residency

  • Boston Combined Residency Program (BCRP) , Boston , MA

Residency

  • Boston Combined Residency Program (BCRP) , Boston , MA

Fellowship

  • Boston Children's Hospital , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Cardiology
  • American Board of Pediatrics, General Pediatrics

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Senescence mechanisms and targets in the heart. Cardiovasc Res. 2021 May 07. View abstract
  2. Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2021 03 12; 12(1):177. View abstract
  3. Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation. Stem Cell Reports. 2020 08 11; 15(2):498-514. View abstract
  4. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Trends Cardiovasc Med. 2021 02; 31(2):85-90. View abstract
  5. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View abstract
  6. Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11. Blood. 2019 11 14; 134(20):1712-1716. View abstract
  7. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence. Circulation. 2020 01 28; 141(4):285-300. View abstract
  8. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. Chem Rev. 2019 11 13; 119(21):11352-11390. View abstract
  9. Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice. . 2019 07 01; 317(1):H201-H212. View abstract
  10. Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. J Mol Cell Cardiol. 2019 03; 128:179-186. View abstract
  11. Engineering of mature human induced pluripotent stem cell-derived cardiomyocytes using substrates with multiscale topography. Advanced Functional Materials. 2018; 19(28):1707378. View abstract
  12. Into the hearts of babes: Stem cell therapy for pediatric heart failure. J Heart Lung Transplant. 2017 08; 36(8):830-832. View abstract
  13. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View abstract
  14. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013 Jun 06; 12(6):689-98. View abstract
  15. Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med. 2013 Apr 01; 3(4):a014019. View abstract
  16. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011 Mar; 32(9):2407-16. View abstract
  17. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules. 2010 Jul 12; 11(7):1833-9. View abstract
  18. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens. 2005 Jan; 27(1):71-82. View abstract
  19. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng. 2004 Jan-Feb; 10(1-2):63-71. View abstract